Biotech | April 10, 2022
LivaNova initiates targeted commercial launch of Essenz patient monitor
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
Dr. Kalyan Banerjee's Clinic developed a homeopathy prophylaxis protocol for the prevention of Covid-19 as soon as the pandemic began
Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect
The hospital is committed to adding to specialised practices in the healthcare space with its pioneering effort to promote oral health awareness and tobacco addiction prevention
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
Essent continues to broaden its highly characterized, low passage primary cell catalog
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis
Subscribe To Our Newsletter & Stay Updated
